IP Verse

Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal Cancer - EP3464373B1

PatentPatent Analysis

EP3464373

BRISTOL MYERS SQUIBB
Application Number
EP17731359A
Filing Date
Jun 2, 2017
Status
Revoked
Aug 4, 2023
Grant Date
Oct 27, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3781132B1
EP3818078B1
EP3631454B1

Bibliography

The patent EP3464373B1 was granted to Bristol Myers Squibb on Oct 27, 2021 following the initial filing on Jun 2, 2017 under the application number EP17731359A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GREINERJul 27, 2022ADMISSIBLE
LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBJul 26, 2022ADMISSIBLE
MAIWALDJul 26, 2022ADMISSIBLE
PAJAROJul 26, 2022ADMISSIBLE
POHLMANJul 26, 2022ADMISSIBLE
MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBJul 25, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents